BioCryst Pharmaceuticals (BCRX) News Today
BCRX rose 2.30% in the 10 minutes after this headline crossed at 07:06:47 ET on Wednesday, Nov 4:
BioCryst Pharma Raises FY2026 Sales Guidance from $690.000M-$715.000M to $715.000M-$730.000M vs $710.134M Est
Price 8.68 two minutes before the headline, 8.88 10 minutes after it.
Latest headline on this page:
Ask ChatGPT about BCRXAsk Claude about BCRXConnect MoveSurge to your assistant
2 headlines on BioCryst Pharmaceuticals appeared in our news feed in the last 7 days with a measured price reaction attached. 2 of them moved the underlying at least 0.35% in the minutes after the headline crossed. The largest measured reaction was +2.30% over 10 minutes on BCRX, after the headline at Nov 4, 07:06:47 ET.
Price action when the news broke
07:06:47 ET
What moved BCRX — last 7 days
| Time | Headline | 1 min | Reaction |
|---|---|---|---|
| Nov 4, 07:06:47 ET | BioCryst Pharma Raises FY2026 Sales Guidance from $690.000M-$715.000M to $715.000M-$730.000M vs $710.134M Est | +1.04% | +2.30% · 10m |
| Nov 4, 07:04:20 ET | BioCryst Pharma Q3 EPS $0.14 Beats $0.08 Estimate, Sales $180.292M Beat $165.674M EstimateVolume 5.2K shares in 10 min | +0.23% | +1.82% · 10m |
Moves are measured against the price two minutes before each headline crossed, using validated 1-minute bars captured at publish time. A dash means no bar was available for that window. Reaction pending means the measuring window for that headline is still open. Not attributed means the headline does not name the company the move was measured on, so we hold the number back. Times are New York ET. Headlines appear here 1 minute after they cross the live tape.